
Will GoodRX Stock Bounce Back?
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Date | Quarter | Revenue Forecast | Actual Revenue | Reported EPS | Consensus EPS | Beat/Miss |
---|---|---|---|---|---|---|
08/28/2025 | Q3 | $1.1B | -- | -- | $1.06 | -- |
05/29/2025 | Q2 | $995.2M | $1B | $0.44 | $0.93 | -$0.49 |
03/06/2025 | Q1 | $980.9M | $964.7M | $0.52 | $0.91 | -$0.39 |
12/05/2024 | Q4 | $1B | $1B | $0.58 | $1.00 | -$0.42 |
08/28/2024 | Q3 | $997.3M | $1B | $0.52 | $0.91 | -$0.39 |
05/30/2024 | Q2 | $949.3M | $942.6M | $0.44 | $0.83 | -$0.39 |
02/29/2024 | Q1 | $917.5M | $931.6M | $0.41 | $0.78 | -$0.37 |
12/07/2023 | Q4 | $923.9M | $927.1M | $0.43 | $0.87 | -$0.45 |
08/30/2023 | Q3 | $901.2M | $930.2M | $0.43 | $0.84 | -$0.41 |
06/01/2023 | Q2 | -- | $877.4M | $0.20 | -- | -- |
03/02/2023 | Q1 | -- | $858.5M | $0.43 | -- | -- |
12/08/2022 | Q4 | -- | $848.1M | $0.33 | -- | -- |
08/31/2022 | Q3 | -- | $843.4M | $0.50 | -- | -- |
06/02/2022 | Q2 | -- | $829.8M | $0.64 | -- | -- |
03/03/2022 | Q1 | -- | $787.2M | $0.48 | -- | -- |
12/02/2021 | Q4 | -- | $759.1M | $0.55 | -- | -- |
09/02/2021 | Q3 | -- | $763.4M | $3.09 | -- | -- |
06/03/2021 | Q2 | -- | $719.5M | $0.59 | -- | -- |
03/04/2021 | Q1 | -- | $680.5M | $10.58 | -- | -- |
12/03/2020 | Q4 | -- | $681.6M | $0.41 | -- | -- |
09/03/2020 | Q3 | -- | $578.2M | $0.28 | -- | -- |
06/04/2020 | Q2 | -- | $524.9M | $0.06 | -- | -- |
03/05/2020 | Q1 | -- | $646.2M | $0.46 | -- | -- |
12/05/2019 | Q4 | -- | $691.6M | $0.61 | -- | -- |
08/29/2019 | Q3 | -- | $679.4M | $0.60 | -- | -- |
05/30/2019 | Q2 | -- | $654.3M | $0.61 | -- | -- |
03/05/2019 | Q1 | -- | $628.1M | $0.52 | -- | -- |
12/06/2018 | Q4 | -- | $651.5M | $0.51 | -- | -- |
08/30/2018 | Q3 | -- | $660M | $0.51 | -- | -- |
06/07/2018 | Q2 | -- | $631.3M | $0.31 | -- | -- |
03/08/2018 | Q1 | -- | $590M | -$0.63 | -- | -- |
12/07/2017 | Q4 | -- | $561.5M | $0.45 | -- | -- |
08/31/2017 | Q3 | -- | $556M | $0.52 | -- | -- |
06/01/2017 | Q2 | -- | $522.4M | $0.53 | -- | -- |
03/02/2017 | Q1 | -- | $499.1M | $0.38 | -- | -- |
12/08/2016 | Q4 | -- | $518.6M | $0.31 | -- | -- |
09/01/2016 | Q3 | -- | $514.7M | $0.45 | -- | -- |
06/02/2016 | Q2 | -- | $483.8M | $0.38 | -- | -- |
03/03/2016 | Q1 | -- | $449.6M | $0.26 | -- | -- |
12/03/2015 | Q4 | -- | $455.6M | $0.19 | -- | -- |
09/03/2015 | Q3 | -- | $461.7M | $0.23 | -- | -- |
The Cooper Companies reported $1B worth of top line sales in its most recent quarter.
The Cooper Companies announced earnings per share of $0.44 which represents a miss of analyst forecast a $0.93 per share.
The Cooper Companies reported $679.1M that represents $3.38 per share over the last quarter.
The Cooper Companies's earnings are forecast to grow from $1.96 per share to $3.65 per share next year representing an increase of 107.23%.
The Cooper Companies's next earnings date is August 28, 2025.
Signup to receive the latest stock alerts
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Freeport-McMoRan (NYSE:FCX) is among the world’s largest producers of copper…
Levi Strauss (NYSE:LEVI) is among the oldest clothing brands in…
Market Cap: $4.2T
P/E Ratio: 58x
Market Cap: $3.8T
P/E Ratio: 43x
Market Cap: $3.1T
P/E Ratio: 35x
SharpLink Gaming [SBET] is down 2.6% over the past day.
Exodus Movement [EXOD] is down 4.14% over the past day.
Unity Software [U] is up 7.51% over the past day.